Product NDC: | 13537-336 |
Proprietary Name: | ESIKA |
Non Proprietary Name: | Octinoxate, Oxybenzone, and Titanium Dioxide |
Active Ingredient(s): | .07; .02; .02 g/g; g/g; g/g & nbsp; Octinoxate, Oxybenzone, and Titanium Dioxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | POWDER |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-336 |
Labeler Name: | Ventura Corporation (San Juan, P.R) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110517 |
Package NDC: | 13537-336-02 |
Package Description: | 1 CASE in 1 BOX (13537-336-02) > 6 g in 1 CASE (13537-336-01) |
NDC Code | 13537-336-02 |
Proprietary Name | ESIKA |
Package Description | 1 CASE in 1 BOX (13537-336-02) > 6 g in 1 CASE (13537-336-01) |
Product NDC | 13537-336 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Octinoxate, Oxybenzone, and Titanium Dioxide |
Dosage Form Name | POWDER |
Route Name | TOPICAL |
Start Marketing Date | 20110517 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura Corporation (San Juan, P.R) |
Substance Name | OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE |
Strength Number | .07; .02; .02 |
Strength Unit | g/g; g/g; g/g |
Pharmaceutical Classes |